Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)
Close on Nov 17, 2026Market cap $545.36KP/E –Yield –
Clearmind Medicine operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Clearmind Medicine's operating cash flow for the twelve months ending Jul 31, 2026 was -$7.07M. For fiscal 2025 it was -$4.73M. The highest annual figure on record is -$2.08M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | -$4.73M | – |
| FY2024 | Oct 31, 2024 | -$4.86M | – |
| FY2023 | Oct 31, 2023 | -$6.30M | – |
| FY2022 | Oct 31, 2022 | -$3.72M | – |
| FY2021 | Oct 31, 2021 | -$2.08M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | -$1.93M | – |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | -$1.77M | – |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | -$2.08M | – |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | -$1.29M | – |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | -$1.08M | – |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | -$1.10M | – |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | -$1.27M | – |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | -$1.08M | – |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | -$1.13M | – |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | -$1.19M | – |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | -$1.46M | – |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | -$753.17K | – |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | -$1.38M | – |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | -$1.07M | – |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | -$3.10M | – |
See a number that looks wrong?